| | Gender | Age (yr) | Diagnosis | Drugs |
| | Normolipidemic
|
| | F | 46 | APS | None | | F | 55 | HT | Valsartan, 40 mg | | F | 60 | GD | Thiamazole, 20 mg | | F | 60 | GD | Thiamazole, 7.5 mg | | F | 62 | HT | Amlodipine, 5 mg | | F | 64 | Osteoporosis | Alfacalcidol, 0.5 g; calcium carbonate 1.0 g | | F | 65 | IHA | Spironolactone, 75 mg | | F | 68 | None | None | | F | 68 | VSA | Diltiazem-R, 100 mg | | F | 73 | None | None | | F | 77 | GD | Thiamazole, 30 mg; propranolol, 30 mg1 | | M | 41 | HT | Candesartan, 8 mg | | M | 43 | IDA | Dried ferrous sulfate, 210 mg | | M | 44 | GD | Propylthiouracil, 200 mg | | M | 56 | GD, PUD | Thiamazole, 20 mg; lansoprazole, 15 mg; sucralfate, 3.0 g | | M | 66 | None | None | | M | 68 | HT | Amlodipine, 5 mg | | M | 76 | None | None |
| | mean | 61 ± 11 | | |
| | Hyperlipidemic |
| | F | 51 | HL | None | | F | 56 | HL, HT | Valsartan, 80 mg | | F | 63 | HL | None | | F | 63 | HL | None | | F | 64 | HL | None | | F | 65 | HL, HT | Amlodipine, 5 mg | | F | 71 | HL, HT, T2DM, CSA | Losartan, 50 mg; benidipine, 4 mg; metformin, 750 mg; ticlopidine, 200 mg; nicorandil, 15 mg | | F | 73 | HL, HT | Manidipine, 40 mg | | F | 74 | HL | None | | F | 75 | HL, HT, T2DM | Amlodipine, 5 mg; losartan, 50 mg; gliclazide, 160 mg | | M | 43 | HL | None | | M | 48 | HL, HT | Candesartan, 12 mg | | M | 51 | HL, gout | Atorvastatin, 10 mg; allopurinol, 100 mg | | M | 66 | HL, HT, VSA, gout | Losartan, 50 mg; diltiazem-R, 100 mg; allopurinol, 100 mg | | M | 68 | HL, HT, PS | Amlodipine, 5 mg; enalapril, 5 mg; amantadine, 150 mg; levodopa, 200 mg | | M | 73 | HL, HT, PUD | Barnidipine, 10 mg; prazosin, 0.25 mg; lansoprazole, 15 mg |
| | mean | 62 ± 12 | | |
|
|
